Log in
Enquire now
‌

US Patent 12016873 Methods for treating pulmonary non-tuberculous mycobacterial infections

Patent 12016873 was granted and assigned to Insmed on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Insmed
Insmed
0
Current Assignee
Insmed
Insmed
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120168730
Patent Inventor Names
Gina Eagle0
Renu Gupta0
Date of Patent
June 25, 2024
0
Patent Application Number
178834910
Date Filed
August 8, 2022
0
Patent Citations
‌
US Patent 6915962 Apparatus for providing aerosol for medical treatment and methods
0
‌
US Patent 6916490 Controlled release of bioactive substances
0
‌
US Patent 6948491 Convertible fluid feed system with comformable reservoir and methods
0
‌
US Patent 6962151 Inhalation nebulizer
0
‌
US Patent 6983747 Aerosol generator
0
‌
US Patent 6991809 Particles with improved solubilization capacity
0
‌
US Patent 7059320 Inhalation therapy apparatus
0
‌
US Patent 7063860 Application of lipid vehicles and use for drug delivery
0
...
Patent Primary Examiner
‌
Michael P Cohen
0
CPC Code
‌
A61K 9/0019
0
‌
A61K 9/0053
0
‌
A61K 9/0078
0
‌
A61K 9/127
0
‌
A61K 31/133
0
‌
A61K 31/407
0
‌
A61K 31/4375
0
‌
A61K 31/4409
0
...
Patent abstract

Provided herein are methods for treating a pulmonary infection in a patient in need thereof, for example, a nontuberculous mycobacterial pulmonary infection for at least one treatment cycle. The method comprises administering to the lungs of the patient a pharmaceutical composition comprising a liposomal complexed aminoglycoside comprising a lipid component comprising electrically neutral lipids and an aminoglycoside. Administration comprises aerosolizing the pharmaceutical composition to provide an aerosolized pharmaceutical composition comprising a mixture of free aminoglycoside and liposomal complexed aminoglycoside, and administering the aerosolized pharmaceutical composition via a nebulizer to the lungs of the patient. The methods provided herein result in a change from baseline on the semi-quantitative scale for mycobacterial culture for a treated patient, and/or NTM culture conversion to negative during or after the administration period.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 12016873 Methods for treating pulmonary non-tuberculous mycobacterial infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.